Zobrazeno 1 - 10
of 236
pro vyhledávání: '"Koichiro Tsuchiya"'
Autor:
Aoi Suenaga, Yasuyuki Seto, Masafumi Funamoto, Masaki Imanishi, Koichiro Tsuchiya, Yasumasa Ikeda
Publikováno v:
Journal of Pharmacological Sciences, Vol 153, Iss 1, Pp 31-37 (2023)
Background and purpose: TJ-17 (Goreisan), a traditional Japanese Kampo medicine, has been generally used to treat edema, such as heart failure, due to its diuretic effect. In the present study, we investigate the effects of TJ-17 on chronic kidney di
Externí odkaz:
https://doaj.org/article/fc0b9a89c0c5433db3fbe99a2ebec64a
Publikováno v:
Frontiers in Cardiovascular Medicine, Vol 10 (2023)
Heart failure results from various physiological and pathological stimuli that lead to cardiac hypertrophy. This pathological process is common in several cardiovascular diseases and ultimately leads to heart failure. The development of cardiac hyper
Externí odkaz:
https://doaj.org/article/71697c24eb53469f8afd0e5fe2b1b743
Autor:
Takeo Minamikawa, Takaaki Koma, Akihiro Suzuki, Takahiko Mizuno, Kentaro Nagamatsu, Hideki Arimochi, Koichiro Tsuchiya, Kaoru Matsuoka, Takeshi Yasui, Koji Yasutomo, Masako Nomaguchi
Publikováno v:
Scientific Reports, Vol 11, Iss 1, Pp 1-9 (2021)
Abstract Inactivation technology for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is certainly a critical measure to mitigate the spread of coronavirus disease 2019 (COVID-19). A deep ultraviolet light-emitting diode (DUV-LED) would b
Externí odkaz:
https://doaj.org/article/86cd4db202ac40e981c77988641100fd
Autor:
Takeo Minamikawa, Takaaki Koma, Akihiro Suzuki, Takahiko Mizuno, Kentaro Nagamatsu, Hideki Arimochi, Koichiro Tsuchiya, Kaoru Matsuoka, Takeshi Yasui, Koji Yasutomo, Masako Nomaguchi
Publikováno v:
Scientific Reports, Vol 11, Iss 1, Pp 1-1 (2021)
Externí odkaz:
https://doaj.org/article/2815659fb2e14ce78eb4345637c30936
Autor:
Yoshito Zamami, Takahiro Niimura, Toshihiro Koyama, Yuta Shigemi, Yuki Izawa-Ishizawa, Mizuki Morita, Ayako Ohshima, Keisaku Harada, Toru Imai, Hiromi Hagiwara, Naoto Okada, Mitsuhiro Goda, Kenshi Takechi, Masayuki Chuma, Yutaka Kondo, Koichiro Tsuchiya, Shiro Hinotsu, Mitsunobu R. Kano, Keisuke Ishizawa
Publikováno v:
Frontiers in Pharmacology, Vol 10 (2019)
The survival rate of cardiac arrest patients is less than 10%; therefore, development of a therapeutic strategy that improves their prognosis is necessary. Herein, we searched data collected from medical facilities throughout Japan for drugs that imp
Externí odkaz:
https://doaj.org/article/160330fc247d43b59aa3ba90d25cc60b
Autor:
Yu Zhou, Yukio Yamamura, Masatoshi Ogawa, Ryosuke Tsuji, Koichiro Tsuchiya, Jiro Kasahara, Satoshi Goto
Publikováno v:
Frontiers in Pharmacology, Vol 9 (2018)
Parkinson’s disease (PD) is caused by a progressive degeneration of nigral dopaminergic cells leading to striatal dopamine deficiency. From the perspective of antiparkinsonian drug mechanisms, pharmacologic treatment of PD can be divided into sympt
Externí odkaz:
https://doaj.org/article/c0cc3c6dc4a6413d88c235d246cd8e92
Autor:
Shuhei Tomita, Yoshitaka Kihira, Masaki Imanishi, Yayoi Fukuhara, Yuko Imamura, Keisuke Ishizawa, Yasumasa Ikeda, Koichiro Tsuchiya, Toshiaki Tamaki
Publikováno v:
Journal of Pharmacological Sciences, Vol 115, Iss 4, Pp 433-439 (2011)
Recent studies have shown that the cellular immune response to the hypoxic microenvironment constructed by vascular remodeling development modulates the resulting pathologic alterations. A major mechanism mediating adaptive responses to reduced oxyge
Externí odkaz:
https://doaj.org/article/97b69e8c322d4d8a95a6318870858f91
Autor:
Keisuke Ishizawa, Masanori Yoshizumi, Yoshichika Kawai, Junji Terao, Yoshitaka Kihira, Yasumasa Ikeda, Shuhei Tomita, Kazuo Minakuchi, Koichiro Tsuchiya, Toshiaki Tamaki
Publikováno v:
Journal of Pharmacological Sciences, Vol 115, Iss 4, Pp 466-470 (2011)
Quercetin, a member of the bioflavonoids family, has been proposed to have antiatherogenic, anti-inflammatory, and anti-hypertensive properties leading to the beneficial effects against cardiovascular diseases. It was recently demonstrated that querc
Externí odkaz:
https://doaj.org/article/7b9341f698fd4330953a39ef6a266d36
Autor:
Keisuke Ishizawa, Yuki Izawa-Ishizawa, Sachiyo Ohnishi, Yuki Motobayashi, Kazuyoshi Kawazoe, Shuichi Hamano, Koichiro Tsuchiya, Shuhei Tomita, Kazuo Minakuchi, Toshiaki Tamaki
Publikováno v:
Journal of Pharmacological Sciences, Vol 109, Iss 2, Pp 257-264 (2009)
Many epidemiologic studies have reported that dietary flavonoids provide protection against cardiovascular disease. Quercetin, a member of the bioflavonoids family, has been proposed to have anti-inflammatory, anti-atherogenic, and anti-hypertensive
Externí odkaz:
https://doaj.org/article/d34a269c368a4303931e8f4213ba7864
Autor:
Keisuke Ishizawa, Kunihisa Yamaguchi, Yuya Horinouchi, Yayoi Fukuhara, Soichiro Tajima, Shuichi Hamano, Shuhei Tomita, Koichiro Tsuchiya, Toshiaki Tamaki
Publikováno v:
Journal of Pharmacological Sciences, Vol 109, Iss 1, Pp 14-19 (2009)
Chronic kidney disease (CKD) is becoming a major public health problem worldwide. It is important to protect endothelial function in CKD treatment because injury of the endothelium is a critical event for the generation and progression of CKD. Recent
Externí odkaz:
https://doaj.org/article/fb4e0cfa7a6840d08a7e86a58ebfb60f